Company Filing History:
1 out of 23 
1 out of 18 Years Active: 2015-2021
Title: Christopher Meier: Innovator in Medicinal Chemistry
Introduction
Christopher Meier is a notable inventor based in Kiel, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for cancer therapy. With a total of 2 patents, his work is recognized for its potential impact on medical treatments.
Latest Patents
Among his latest patents, Meier has developed pyrido-phenanthroline derivatives, which are innovative compounds with applications in medicine. These derivatives are particularly focused on cancer therapy, showcasing their potential as effective medicaments. His inventions include pyrido [3,4-C] [1,9] phenanthroline and 11, 12 dihydropyrido [3,4-C] [1,9] phenanthroline derivatives, which are designed for treating cancer. The methods for producing these compounds are also outlined in his patents, emphasizing their significance in drug development.
Career Highlights
Throughout his career, Christopher Meier has been associated with prestigious institutions such as Christian-Albrechts-Universität zu Kiel. His work at this university has allowed him to explore and innovate in the field of medicinal chemistry, contributing to advancements in cancer treatment.
Collaborations
Meier has collaborated with notable colleagues, including Bernd Clement and Dieter Heber. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment for innovation.
Conclusion
Christopher Meier stands out as an influential inventor in the realm of medicinal chemistry, with a focus on developing innovative solutions for cancer therapy. His contributions through patents and collaborations highlight his commitment to advancing medical science.